In general, exons with non complementing dpolv mutations do not show marked 5' end conservation.
0.178 and 0.512 respectively and each is marked by two non complementing dpolv nonsense mutations, dpolvR11 and dpolvD2011A in exon 19, and dpolv2C1 and dpolv89a in exon 34.
Strains and plasmids used for the secretion assay (Supplementary file 1B, C ): E40 (WT); Δ yscD (AD4051), non-complemented or complemented in trans with yscD (from pMA11), or with yscD G283P (from pUW22).
The process in which complement-coated IgA1 antibodies transferred to non-complement-coated antigens is termed complement-coated antibody-transfer/transport (CCAT).
It also alludes to the potential use of this hybrid technique to differentiate between non-specific binding and non-specific adsorption of non-complement targets onto the sensor surface.
Although alemtuzumab has not been able to induce allograft tolerance as was initially hoped, it is assumed that both complement and non-complement-mediated mechanisms are similarly responsible for alemtuzumab-mediated killing of T cells.
Furthermore, since we observed significant reduction in CAIA induced only with complement fixing antibodies, another possibility for the inefficiency of C5aR blockade might be attributed to the presence of non-complement fixing antibody subclasses in RA patients but this information is not available for that study [39].
The C1q assay is another test that is designed to distinguish complement-fixing from non-complement-fixing antibodies 56.
In these mice, while both non-complement-fixing IgG1 and complement-fixing IgG2a and IgG2b autoantibodies are produced after immunization, IgG2a/b autoantibodies seem to induce blistering [ 68].
The cELISA offers the possibility for automatisation, can be applied to non-complement fixing sera and used for various host species.
Experimental evidence using a murine model of pemphigus vulgaris shows that, similar to human pemphigus, the autoimmune response in mice is biased toward non-complement fixing autoantibodies.
